STROKE GENETICS – Stéphanie Debette & Martin Dichgans
Stéphanie Debette, MD PhD, is Professor of Epidemiology/Public Health at the university of Bordeaux and practicing Neurologist at Bordeaux University Hospital. She serves as Director of the Inserm Bordeaux Population Health research center. Prof. Debette has been leading large collaborative genomic and epidemiological studies on stroke, cognitive traits, and imaging markers of brain aging, especially cerebral small vessel disease, aiming to decipher the molecular mechanisms underlying brain aging and to improve prevention and treatment of stroke and dementia. Prof. Debette leads a European Research Council grant and is principal investigator of national investment for the future and European grants. She has been awarded the Claude Pompidou Foundation prize for dementia research and the scientific excellence award of the European Stroke Organization. A former Fulbright and Bettencourt-Schueller fellow and adjunct associate professor at Boston University, she was a visiting professor at Kyoto University. She collaborates closely with the CHARGE consortium where she serves in the research steering committee and chaired the International Stroke Genetics Consortium (ISGC) between 2017 and 2019.
Martin Dichgans is a Professor of Neurology at Ludwig-Maximilians-Universität, LMU (Munich, Germany). He is the Founding Director of the Institute for Stroke and Dementia Research and President of the European Stroke Organization (ESO). His major research interest is in the mechanisms, diagnosis and treatment of cerebral small vessel disease (SVD), stroke and vascular dementia with a focus on genetics, molecular and cellular biology, and the conduct of investigator-initiated studies.
Dr. Dichgans authored over 550 research articles, reviews, and editorials. He served as a coordinator / principal investigator of various national (e.g. DZNE), EU (FP7 & Horizon2020) and transatlantic (Fondation Leducq) research grants, and is in leadership positions at national and international conferences on stroke and dementia. Dr. Dichgans coordinates multicenter clinical trials on SVD and atherosclerosis and has contributed to national and international stroke guidelines and expert statements. He is / has been on the Editorial Board of the journals Annals of Neurology, Stroke, European Stroke Journal, International Journal of Stroke, and Frontiers in Stroke. Dr. Dichgans chaired the scientific advisory board of the EU ERANET Neuron. He further serves on the research committee of the World Stroke Association (WSO) and the board of directors of the DFG-funded Excellence Cluster Munich Cluster of Systems Neurology.